Type Whole antibody Target mesothelin CAS Number 931402-35-6 | Source Chimeric (mouse/human) ATC code none ChemSpider none | |
Amatuximab is a chimeric monoclonal antibody designed for the treatment of cancer.
Amatuximab was developed by Morphotek, Inc.
Amatuximab is also known as Anti-mesothelin monoclonal antibody MORAb-009. Amatuximab is an anti-mesothelin monoclonal antibody MORAb-009 binds to mesothelin (a protein that is made by some cancer cells) and stops the cells from dividing, and also called MORAb-009.
References
Amatuximab Wikipedia(Text) CC BY-SA